Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer.

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer. Br J Cancer. 2017 May 09; 116(10):1264-1270.

View in: PubMed

subject areas

Aged
Antineoplastic Combined Chemotherapy Protocols
CA-19-9 Antigen
Capecitabine
Chemoradiotherapy
Deoxycytidine
Disease-Free Survival
Female
Follow-Up Studies
Humans
Induction Chemotherapy
Male
Middle Aged
Neoplasm Staging
Pancreatic Neoplasms
ROC Curve
Severity of Illness Index
Survival Rate
Time Factors
Tumor Burden

authors with profiles

Ross Abrams